COCCO, ELEONORA
 Distribuzione geografica
Continente #
EU - Europa 495.677
NA - Nord America 30.423
AS - Asia 12.004
SA - Sud America 1.943
Continente sconosciuto - Info sul continente non disponibili 1.418
AF - Africa 311
OC - Oceania 32
Totale 541.808
Nazione #
IT - Italia 488.165
US - Stati Uniti d'America 29.766
SG - Singapore 4.712
CN - Cina 3.858
BR - Brasile 1.491
SE - Svezia 1.309
UA - Ucraina 1.267
NL - Olanda 1.258
VN - Vietnam 1.102
DE - Germania 901
GB - Regno Unito 723
FI - Finlandia 714
FR - Francia 616
HK - Hong Kong 446
BD - Bangladesh 414
CA - Canada 358
IN - India 267
KR - Corea 186
AR - Argentina 157
TR - Turchia 123
JP - Giappone 116
IQ - Iraq 115
RU - Federazione Russa 112
MX - Messico 106
ZA - Sudafrica 95
ES - Italia 88
AT - Austria 81
PL - Polonia 80
PK - Pakistan 75
ID - Indonesia 66
MA - Marocco 65
EC - Ecuador 63
CO - Colombia 62
UZ - Uzbekistan 56
VE - Venezuela 56
BE - Belgio 54
PH - Filippine 52
IR - Iran 50
SA - Arabia Saudita 49
CL - Cile 40
IL - Israele 39
CR - Costa Rica 37
MY - Malesia 37
CZ - Repubblica Ceca 36
IE - Irlanda 36
JM - Giamaica 36
LT - Lituania 33
AE - Emirati Arabi Uniti 26
AU - Australia 26
EU - Europa 25
KE - Kenya 25
TN - Tunisia 25
AZ - Azerbaigian 24
JO - Giordania 24
EG - Egitto 23
DZ - Algeria 22
GT - Guatemala 21
GR - Grecia 20
NP - Nepal 20
UY - Uruguay 20
RO - Romania 19
PY - Paraguay 18
CH - Svizzera 17
HR - Croazia 17
HN - Honduras 16
PE - Perù 16
TH - Thailandia 16
AL - Albania 15
BO - Bolivia 15
OM - Oman 15
PT - Portogallo 15
TW - Taiwan 15
KZ - Kazakistan 14
PS - Palestinian Territory 14
DK - Danimarca 13
EE - Estonia 13
BG - Bulgaria 11
HU - Ungheria 11
PR - Porto Rico 11
SN - Senegal 11
DO - Repubblica Dominicana 10
LB - Libano 10
RS - Serbia 10
BB - Barbados 9
CI - Costa d'Avorio 9
ET - Etiopia 9
KG - Kirghizistan 9
KW - Kuwait 9
NI - Nicaragua 9
SV - El Salvador 9
TT - Trinidad e Tobago 9
PA - Panama 8
MD - Moldavia 7
NG - Nigeria 7
GE - Georgia 6
GP - Guadalupe 6
LV - Lettonia 6
NO - Norvegia 6
NZ - Nuova Zelanda 6
SK - Slovacchia (Repubblica Slovacca) 6
Totale 540.321
Città #
Cagliari 474.932
Uta 10.670
Ashburn 3.807
Singapore 2.388
Fairfield 2.335
San Jose 1.814
Woodbridge 1.770
Dallas 1.290
Chandler 1.198
Houston 1.133
Boardman 1.109
Amsterdam 1.102
Wilmington 985
Seattle 958
Ann Arbor 829
Cambridge 781
Beijing 725
Nyköping 710
Los Angeles 646
Council Bluffs 621
Jacksonville 598
New York 530
Helsinki 466
Hong Kong 400
Santa Clara 398
Chicago 390
Dearborn 366
Lauterbourg 331
The Dalles 322
Ho Chi Minh City 313
Munich 291
Nanjing 287
Shanghai 279
Boston 265
Hefei 257
Buffalo 246
Milan 238
Hanoi 236
Rome 228
Seoul 175
São Paulo 161
Salt Lake City 151
Toronto 148
San Diego 143
Phoenix 134
Guangzhou 131
Atlanta 128
Columbus 124
Dong Ket 122
London 119
Orem 105
Shenyang 100
Norwalk 99
Nanchang 96
Redwood City 90
Tokyo 87
Elk Grove Village 84
Brooklyn 83
Redondo Beach 83
Carrboro 81
Washington 81
Jiaxing 80
Frankfurt am Main 77
Tampa 75
Hebei 71
Sassari 71
Montreal 69
Denver 64
Changsha 63
Tianjin 61
Warsaw 61
Nuremberg 55
Da Nang 54
Verona 54
Johannesburg 53
Miami 52
Detroit 49
Tashkent 49
Stockholm 46
Baghdad 45
San Francisco 45
Rio de Janeiro 43
Vienna 43
Jinan 42
Mexico City 42
Naples 41
Chennai 40
North Bergen 40
Shenzhen 40
Sterling 40
Florence 39
Hangzhou 39
Istanbul 39
Turku 37
Brussels 36
Mountain View 36
Zhengzhou 36
Düsseldorf 34
Haiphong 33
Turin 33
Totale 520.696
Nome #
Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation 6.171
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis 6.015
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles 5.264
Erratum to: Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population (Neurological Sciences, (2017), 38, 6, (1019-1025), 10.1007/s10072-017-2905-x 4.954
Evaluation of Stroop color word test as cognitive task to investigate cognitive motor interference during walking in Multiple Sclerosis 4.599
EFFECTS OF SIX MONTHS TRAINING ON PHYSICAL CAPACITY AND METABOREFLEX ACTIVITY IN PATIENTS WITH MULTIPLE SCLEROSIS. 4.514
Quantitative assessment of alterations induced by spasticity on gait of individuals with multiple sclerosis using 3D gait analysis 4.506
Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia 4.422
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients 4.332
The burden of multiple sclerosis variants in continental Italians and Sardinians 4.232
Quantitative assessment of the effects of 6 months of adapted physical activity on gait in people with multiple sclerosis: a randomized controlled trial 4.231
Overexpression of the cytokine BAFF and autoimmunity risk 4.152
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 4.070
Assessment of geochemical factors in multiple sclerosis distribution in the South-Western Sardinia 4.041
HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia 4.008
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features 3.966
What do multiple sclerosis patients and their caregivers perceive as unmet needs? 3.917
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test 3.859
Clinical Assessment of Gait in Individuals with Multiple Sclerosis Using Wearable Inertial Sensors: Comparison with Patient-Based Measure 3.855
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.843
Effectiveness and Limitations of Unsupervised Home-Based Balance Rehabilitation with Nintendo Wii in People with Multiple Sclerosis 3.817
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial 3.746
The Required Coefficient of Friction for evaluating gait alterations in people with Multiple Sclerosis during gait 3.722
Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers 3.680
Walking improvements with nabiximols in patients with multiple sclerosis 3.662
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection 3.640
Texting while walking differently alters gait patterns in people with multiple sclerosis and healthy individuals 3.634
Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score 3.626
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy 3.620
Factors influencing MS outcome in Sardinia: a clinical and genetic study 3.608
A genetic association study of two genes linked to neurodegeneration in a Sardinian multiple sclerosis population: The TARDBP Ala382Thr mutation and C9orf72 expansion 3.528
The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis 3.453
Impact of brain atrophy on walking in multiple sclerosis patients with low disability: a dual task study. 3.420
Impact of the media on future hope in multiple sclerosis 3.417
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.334
Association between brain atrophy and cognitive motor interference in multiple sclerosis 3.330
Multiple Sclerosis and environmental factors. 3.322
Are static and functional balance abilities related in individuals with Multiple Sclerosis? 3.310
Combining HLA-DRB1-DQB1 and Mycobacterium Avium Subspecies Paratubercolosis (MAP) antibodies in Sardinian multiple sclerosis patients: associated or independent risk factors? 3.309
Cardiac involvement in patients with lamin A/C gene mutations: a cohort observation 3.252
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 3.227
Oral agents in multiple sclerosis 3.222
Influence of treatments in multiple sclerosis disability: a cohort study 3.210
‘Timed up and go’ and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis 3.181
Top-down proteomic profiling of human saliva in multiple sclerosis patients 3.165
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.134
Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity 3.121
Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis 3.121
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study 3.082
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis 3.072
Brain volume in early MS patients with and without IgG oligoclonal bands in CSF 3.061
Smoothness of gait, but not spatio-temporal parameters, are altered in early stages of Multiple Sclerosis 3.009
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis 2.999
Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis 2.998
Refining the connection between gait and cognition: training the body to improve the brain 2.995
Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population 2.989
Effect of 6 months of adapted physical activity on gait patterns in individuals with multiple sclerosis: a three-dimensional quantitative analysis 2.984
Relationship between gait initiation and disability in individuals affected by multiple sclerosis 2.976
Validation of the Arm Profile Score in assessing upper limb functional impairments in people with multiple sclerosis 2.933
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population 2.898
Hourly trends of physical activity in people with Multiple Sclerosis 2.890
Cognition in multiple sclerosis: Between cognitive reserve and brain volume 2.886
Effect of spasticity on kinematics of gait and muscular activation in people with multiple sclerosis 2.827
Do gait patterns differ in men and women with multiple sclerosis? 2.820
Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study 2.742
Postural adaptation during a Nintendo Wii balance training 2.705
Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1 H-NMR Spectroscopy 2.665
Perception of risk and shared decision making process in multiple sclerosis 2.663
Pregnancy planning and outcomes in patients with multiple sclerosis after mitoxantrone therapy: A monocentre assessment 2.657
Smoothness of gait detects early alterations of walking in persons with multiple sclerosis without disability 2.656
Are static and dynamic balance abilities correlated in people with Multiple Sclerosis? 2.628
Cardiac and muscle imaging findings in a family with X-linked Emery-Dreifuss muscular dystrophy 2.624
The relationships between physical activity, self-efficacy, and quality of life in people with multiple sclerosis 2.609
Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia 2.596
Pregnancy outcome in multiple sclerosis women treated with mitoxantrone 2.575
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients 2.549
Geoepidemiology of Multiple Sclerosis: the environmental factors. 2.531
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.517
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patient 2.426
Evaluation of high doses of ascorbic acid efficacy in Charcot Marie Tooth type 1A 2.366
The cohort of the multiple sclerosis center of Cagliari 2.344
Attitude towards physical activity in patients with multiple sclerosis: a cohort study 2.341
Balance patterns in people with multiple sclerosis using Nintendo Wii 2.329
Evolution of the phenotype in a family with an LMNA gene mutation presenting with isolated cardiac involvement 2.315
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.302
Induction and escalation therapies in multiple sclerosis 2.301
Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin-α2-chain gene: a chance association or a novel phenotype? 2.282
Presence of oligoclonal IgG bands in Sardinians with multiple sclerosis is influenced by carriage of different HLA DRB1-DQB1 haplotypes 2.266
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 2.256
Thyroid antibodies in the CSF of Sardinian multiple sclerosis patients 2.248
Aberrant splicing in the LMNA gene caused by a novel mutation on the polypyrimidine tract of intron 5 2.242
Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis 2.240
Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations 2.118
Does focal inflammation have an impact on cognition in multiple sclerosis? An MRI study 2.115
Multiple sclerosis and fertilization in vitro with embryo transfer (FIVET): a case report 2.082
Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population 2.074
Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population 2.073
Tardbp ala382thr mutation in multiple sclerosis: A possible role in brain atrophy 2.072
Partial lipodystrophy associated with muscular dystrophy of unknown genetic origin 2.042
Novel Characterization of Gait Impairments in People with Multiple Sclerosis by Means of the Gait Profile Score 2.041
Totale 317.773
Categoria #
all - tutte 706.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 706.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202219.771 0 0 0 2.039 2.209 1.580 1.217 1.264 2.468 2.858 3.383 2.753
2022/202336.235 3.108 5.156 5.038 3.231 3.069 3.597 1.763 2.760 2.009 2.109 2.761 1.634
2023/202438.874 2.396 1.901 1.510 2.537 3.741 6.434 5.206 3.347 1.961 2.893 3.507 3.441
2024/202598.907 28.032 28.966 11.450 8.286 4.316 4.788 6.787 483 1.114 1.990 1.689 1.006
2025/202626.459 1.758 1.093 2.417 2.373 1.798 1.840 5.513 2.191 1.870 2.380 1.916 1.310
2026/20276.993 834 1.419 1.973 2.767 0 0 0 0 0 0 0 0
Totale 541.808